- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.49 Å
- Oligo State
- homo-12-mer
- Ligands
- 24 x MN: MANGANESE (II) ION(Non-covalent)
- 12 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.3: 15 residues within 4Å:- Chain A: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.2
11 PLIP interactions:10 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:E.207, A:F.225, A:S.273, A:S.273
- Water bridges: A:E.220, A:R.339, A:R.339, A:R.344, B:D.50
- Salt bridges: A:H.271, A:R.344
ADP.8: 15 residues within 4Å:- Chain B: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.7
11 PLIP interactions:10 interactions with chain B, 1 interactions with chain C- Hydrogen bonds: B:E.207, B:F.225, B:S.273, B:S.273
- Water bridges: B:E.220, B:R.339, B:R.339, B:R.344, C:D.50
- Salt bridges: B:H.271, B:R.344
ADP.13: 15 residues within 4Å:- Chain C: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.12
11 PLIP interactions:10 interactions with chain C, 1 interactions with chain D- Hydrogen bonds: C:E.207, C:F.225, C:S.273, C:S.273
- Water bridges: C:E.220, C:R.339, C:R.339, C:R.344, D:D.50
- Salt bridges: C:H.271, C:R.344
ADP.18: 15 residues within 4Å:- Chain D: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.17
11 PLIP interactions:1 interactions with chain E, 10 interactions with chain D- Water bridges: E:D.50, D:E.220, D:R.339, D:R.339, D:R.344
- Hydrogen bonds: D:E.207, D:F.225, D:S.273, D:S.273
- Salt bridges: D:H.271, D:R.344
ADP.23: 15 residues within 4Å:- Chain E: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.22
11 PLIP interactions:10 interactions with chain E, 1 interactions with chain F- Hydrogen bonds: E:E.207, E:F.225, E:S.273, E:S.273
- Water bridges: E:E.220, E:R.339, E:R.339, E:R.344, F:D.50
- Salt bridges: E:H.271, E:R.344
ADP.28: 15 residues within 4Å:- Chain F: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.27
11 PLIP interactions:10 interactions with chain F, 1 interactions with chain A- Hydrogen bonds: F:E.207, F:F.225, F:S.273, F:S.273
- Water bridges: F:E.220, F:R.339, F:R.339, F:R.344, A:D.50
- Salt bridges: F:H.271, F:R.344
ADP.33: 15 residues within 4Å:- Chain G: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.32
11 PLIP interactions:10 interactions with chain G, 1 interactions with chain L- Hydrogen bonds: G:E.207, G:F.225, G:S.273, G:S.273
- Water bridges: G:E.220, G:R.339, G:R.339, G:R.344, L:D.50
- Salt bridges: G:H.271, G:R.344
ADP.38: 15 residues within 4Å:- Chain H: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.37
11 PLIP interactions:10 interactions with chain H, 1 interactions with chain G- Hydrogen bonds: H:E.207, H:F.225, H:S.273, H:S.273
- Water bridges: H:E.220, H:R.339, H:R.339, H:R.344, G:D.50
- Salt bridges: H:H.271, H:R.344
ADP.43: 15 residues within 4Å:- Chain I: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.42
11 PLIP interactions:10 interactions with chain I, 1 interactions with chain H- Hydrogen bonds: I:E.207, I:F.225, I:S.273, I:S.273
- Water bridges: I:E.220, I:R.339, I:R.339, I:R.344, H:D.50
- Salt bridges: I:H.271, I:R.344
ADP.48: 15 residues within 4Å:- Chain J: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.47
11 PLIP interactions:10 interactions with chain J, 1 interactions with chain I- Hydrogen bonds: J:E.207, J:F.225, J:S.273, J:S.273
- Water bridges: J:E.220, J:R.339, J:R.339, J:R.344, I:D.50
- Salt bridges: J:H.271, J:R.344
ADP.53: 15 residues within 4Å:- Chain K: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.52
11 PLIP interactions:10 interactions with chain K, 1 interactions with chain J- Hydrogen bonds: K:E.207, K:F.225, K:S.273, K:S.273
- Water bridges: K:E.220, K:R.339, K:R.339, K:R.344, J:D.50
- Salt bridges: K:H.271, K:R.344
ADP.58: 15 residues within 4Å:- Chain L: L.125, G.127, E.129, E.207, A.222, T.223, R.224, F.225, H.271, S.273, R.344, A.353, R.355, E.357
- Ligands: MN.57
11 PLIP interactions:10 interactions with chain L, 1 interactions with chain K- Hydrogen bonds: L:E.207, L:F.225, L:S.273, L:S.273
- Water bridges: L:E.220, L:R.339, L:R.339, L:R.344, K:D.50
- Salt bridges: L:H.271, L:R.344
- 24 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
MPD.4: 10 residues within 4Å:- Chain A: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.5: 9 residues within 4Å:- Chain A: F.16, F.80, A.81, D.82, T.84
- Chain F: Q.189, D.190, S.193, H.209
Ligand excluded by PLIPMPD.9: 9 residues within 4Å:- Chain A: Q.189, D.190, S.193, H.209
- Chain B: F.16, F.80, A.81, D.82, T.84
Ligand excluded by PLIPMPD.10: 10 residues within 4Å:- Chain B: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.14: 9 residues within 4Å:- Chain B: Q.189, D.190, S.193, H.209
- Chain C: F.16, F.80, A.81, D.82, T.84
Ligand excluded by PLIPMPD.15: 10 residues within 4Å:- Chain C: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.19: 9 residues within 4Å:- Chain C: Q.189, D.190, S.193, H.209
- Chain D: F.16, F.80, A.81, D.82, T.84
Ligand excluded by PLIPMPD.20: 10 residues within 4Å:- Chain D: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.24: 9 residues within 4Å:- Chain D: Q.189, D.190, S.193, H.209
- Chain E: F.16, F.80, A.81, D.82, T.84
Ligand excluded by PLIPMPD.25: 10 residues within 4Å:- Chain E: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.29: 9 residues within 4Å:- Chain E: Q.189, D.190, S.193, H.209
- Chain F: F.16, F.80, A.81, D.82, T.84
Ligand excluded by PLIPMPD.30: 10 residues within 4Å:- Chain F: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.34: 10 residues within 4Å:- Chain G: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.35: 9 residues within 4Å:- Chain G: F.16, F.80, A.81, D.82, T.84
- Chain H: Q.189, D.190, S.193, H.209
Ligand excluded by PLIPMPD.39: 10 residues within 4Å:- Chain H: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.40: 9 residues within 4Å:- Chain H: F.16, F.80, A.81, D.82, T.84
- Chain I: Q.189, D.190, S.193, H.209
Ligand excluded by PLIPMPD.44: 10 residues within 4Å:- Chain I: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.45: 9 residues within 4Å:- Chain I: F.16, F.80, A.81, D.82, T.84
- Chain J: Q.189, D.190, S.193, H.209
Ligand excluded by PLIPMPD.49: 10 residues within 4Å:- Chain J: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.50: 9 residues within 4Å:- Chain J: F.16, F.80, A.81, D.82, T.84
- Chain K: Q.189, D.190, S.193, H.209
Ligand excluded by PLIPMPD.54: 10 residues within 4Å:- Chain K: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIPMPD.55: 9 residues within 4Å:- Chain K: F.16, F.80, A.81, D.82, T.84
- Chain L: Q.189, D.190, S.193, H.209
Ligand excluded by PLIPMPD.59: 9 residues within 4Å:- Chain G: Q.189, D.190, S.193, H.209
- Chain L: F.16, F.80, A.81, D.82, T.84
Ligand excluded by PLIPMPD.60: 10 residues within 4Å:- Chain L: R.20, F.21, T.22, R.88, C.89, D.90, D.103, R.105, D.233, Y.368
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gill, H.S. et al., The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition. Biochemistry (2001)
- Release Date
- 2000-06-28
- Peptides
- GLUTAMINE SYNTHETASE: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
L
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.49 Å
- Oligo State
- homo-12-mer
- Ligands
- 24 x MN: MANGANESE (II) ION(Non-covalent)
- 12 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 24 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gill, H.S. et al., The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition. Biochemistry (2001)
- Release Date
- 2000-06-28
- Peptides
- GLUTAMINE SYNTHETASE: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
L